When it comes to bowel disorders, there is significant overlap among various medical fields. Anorectal manometry (ARM) is a diagnostic tool used in the determination of bowel disorders such as chronic constipation and fecal incontinence. Gastroenterologists commonly administer ARM tests, but should OBGYN physicians offer anorectal manometry as well?
Anorectal manometry (ARM) is a common diagnostic tool for fecal incontinence and constipation. However, it can also be used within care pathways for a number of disorders, which will be described here.
Irritable bowel syndrome is a prevalent disorder, affecting approximately 25 million – 45 million people in the United States alone. To begin treatment, a proper diagnosis of irritable bowel syndrome is important. Here, anorectal manometry as a diagnostic tool1 for irritable bowel syndrome will be discussed.
Disorders of the bowels require specific investigative techniques that are preferably non-invasive for accurate disease diagnosis. Here, the use of anorectal manometry for the diagnosis of Hirschsprung’s disease1 will be discussed.
Urodynamics are a series of tests that measure the functionality of the lower urinary tract. Urodynamics testing1 may be ordered for a number of symptoms, including pain, incontinence, and changes in a patient’s normal urinary or fecal routine.
- Significantly increases BHN’s size and profitability
- Further expands BHN’s geographic footprint into the New England states and Florida
- Expands BHN’s diagnostic services offering
- Increases the depth of BHN’s clinical teams
- Immediately accretive to earnings
See PRNewsWire Press Release here.
Flowood, MS – Brighter Health Network, LLC (BHN), which offers medical diagnostic solutions such as urodynamic testing services, today announced it has acquired Urodynamic Testing Specialists (UTS) for an undisclosed amount. The acquisition is expected to be immediately accretive to earnings and will significantly increase BHN’s top and bottom lines.
Brighter Health Network (BHN), a leading medical diagnostics services company, and Medspira, a leading medical device maker, today announced a national partnership between the two companies to further market, distribute, and service Medspira’s mcompass anorectal manometry system. BHN provides turn-key, on-site medical diagnostics that include equipment, staff, software, and supplies required to perform multiple types of diagnostic testing such as anorectal manometry. As part of this partnership BHN will use Medspira’s equipment and supplies to service clinics and hospitals across the country that desire to offer anorectal manometry. This partnership will enable these clinics and hospitals to offer anorectal manometry testing to their patients without having to purchase expensive equipment, train staff, or incur the other challenges encountered when providing a new service. This will make it extremely easy for the clinics and hospitals to leverage anorectal manometry, which will in turn allow them to better diagnose and treat patients suffering from fecal incontinence, chronic constipation, and other lower gastrointestinal problems.
I recently attended a statewide gastroenterology conference in Mississippi. I got to meet all types of interesting people, including accomplished doctors and their staffs. For this conference I compiled some data on anorectal manometry (ARM) reimbursement rates. Given gastroenterologist use of colonoscopies, I thought it would be useful to compare ARM reimbursements (CPT Codes 91120, 91122, and 51784) to screening colonoscopy reimbursements (CPT Code 45378). I was aware that ARM reimbursed at a better rate, but I was not aware it was substantially better. When looking only at National Medicare reimbursements, anorectal manometry reimburses at a 93% higher rate than a screening colonoscopy. In the chart below you'll see the trend of reimbursements rates both nationally and within the state of Mississippi over the last decade. As you can see, and as every gastroenterologist knows, colonoscopy reimbursement rates have fallen quite significantly and are expected to fall more in coming years. However, ARM shows a more stable reimbursement rate, especially in recent years.